The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel amino-bicyclic pyrimidinone compounds of Formula (I):
1
or a stereoisomer or pharmaceutically acceptable salt form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor Xa, factor XIa, factor IXa, and/or factor VIIa. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
本发明一般涉及抑制
丝氨酸蛋白酶的化合物。具体而言,本发明涉及式(I)的新型
氨基双环
嘧啶酮化合物或其立体异构体或药学上可接受的盐形式,这些化合物可用作凝血级联中
丝氨酸蛋白酶的选择性
抑制剂;例如凝血酶、X因子a、XI因子a、IX因子a和/或VII因子a。特别是,涉及抑制VII因子a的化合物。本发明还涉及包含这些化合物的药物组合物以及使用相同的方法。